Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Philip Fleshner
Introduction
Philip Fleshner is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of medical diagnostics, particularly in relation to inflammatory bowel disease. His work has the potential to improve the lives of many patients suffering from conditions such as Crohn's Disease and Ulcerative Colitis.
Latest Patents
Philip Fleshner holds a patent for "Methods of diagnosing inflammatory bowel disease through RNASET2." This patent describes methods for diagnosing inflammatory bowel disease, including Crohn's Disease, Ulcerative Colitis, and Medically Refractive Ulcerative Colitis. The methods utilize RNA-SET2, TL1A, and/or IFN-Y. Additionally, the patent outlines processes for patient identification and stratification, as well as treatment options involving therapeutic agents.
Career Highlights
Philip Fleshner is affiliated with Cedars-Sinai Medical Center, where he continues to advance his research and innovations. His work at this prestigious institution allows him to collaborate with leading experts in the field of gastroenterology.
Collaborations
Philip has worked alongside esteemed colleagues such as Rebecca Gonsky and Stephan R. Targan. Their combined expertise contributes to the ongoing research and development of effective diagnostic methods for inflammatory bowel disease.
Conclusion
Philip Fleshner's innovative work in diagnosing inflammatory bowel disease showcases his commitment to advancing medical science. His contributions have the potential to significantly impact patient care and treatment options in the future.